Skip to main content
PMC home page
Biomolecules & Therapeutics logoLink to Biomolecules & Therapeutics
. 2016 Jul 1;24(4):395–401. doi: 10.4062/biomolther.2016.020

Aloe-Emodin Induces Chondrogenic Differentiation of ATDC5 Cells via MAP Kinases and BMP-2 Signaling Pathways

Ming Yang 1, Liang Li 2, Seok-Mo Heo 1,*, Yunjo Soh 2,*
PMCID: PMC4930283  PMID: 27350340

Abstract

Endochondral bone formation is the process by which mesenchymal cells condense into chondrocytes, which are ultimately responsible for new bone formation. The processes of chondrogenic differentiation and hypertrophy are critical for bone formation and are therefore highly regulated. The present study was designed to investigate the effect of aloe-emodin on chondrogenic differentiation in clonal mouse chondrogenic ATDC5 cells. Aloe-emodin treatment stimulated the accumulation of cartilage nodules in a dose-dependent manner. ATDC5 cells were treated with aloe-emodin and stained with alcian blue. Compared with the control cells, the ATDC5 cells showed more intense alcian blue staining. This finding suggested that aloe-emodin induced the synthesis of matrix proteoglycans and increased the activity of alkaline phosphatase. Aloe-emodin also enhanced the expressions of chondrogenic marker genes such as collagen II, collagen X, BSP and RunX2 in a time-dependent manner. Furthermore, examination of the MAPK signaling pathway showed that aloe-emodin increased the activation of extracellular signal-regulated kinase (ERK), but had no effect on p38 and c-jun N-terminal kinase (JNK). Aloe-emodin also enhanced the protein expression of BMP-2 in a time-dependent manner. Thus, these results showed that aloe-emodin exhibited chodromodulating effects via the BMP-2 or ERK signaling pathway. Aloe-emodin may have potential future applications for the treatment of growth disorders.

Keywords: Aloe-emodin, ATDC5 cells, Chondrogenesis, MAP kinases, BMP-2

INTRODUCTION

Cartilage is a connective tissue that is comprised primarily of matrix (mainly collagens and proteoglycans) containing relatively sparse populations of chondrocytes, which perform matrix-generation and maintenance functions (Zuscik et al., 2008). Damaged cartilage has limited ability to repair itself. Therefore, focal or diffuse cartilage defects often require orthopedic surgery (Wakitani et al., 1998). Although the number of patients who need such treatment is significantly lower than those with arthritis, localized defects present a possible first step in the regeneration of the articular surface.

Mesenchymal stem cells (MSCs) are a group of cells with multiple differentiation potentials (Jiang et al., 2015). These multipotent cells can be differentiated into chondrocytes, osteoblasts and adipocytes. Due to the development of bone marrow-derived mesenchymal stem cells, MSCs are ideal cells for the treatment of diseases of the musculoskeletal system. Over the past ten years, these cells have been used for the construction of tissue engineered articular cartilage defects and have received great attention in terms of manipulability in vitro (Pittenger et al., 1999).

Natural anthraquinone derivatives are found in the root extracts, bark or leaves of many plants used primarily as laxatives. Over the last few decades, these compounds have been investigated as potential cancer treatments (Mueller et al., 1998; Huang et al., 2005; Kim et al., 2005; Mijatovic et al., 2005; Lin et al., 2006). Rhubarb (Rheum rhabarbarum) is a well-known traditional Chinese herbal medicine commonly used to treat constipation, jaundice, gastrointestinal hemorrhage, and ulcers (Hu et al., 2014). Anthraquinone derivatives, including emodin and aloe-emodin, are the main active ingredients found in rhubarb (Komatsu et al., 2006).Emodin reportedly have a variety of biology activities, such as anti-inflammatory and anticancer. Emodin also induced osteoblast differentiation and increased the area of new bone formation by inducing BMP-2 through activation of the MAP kinase-NF-κB signaling pathway in MC3T3-El cells (Kim et al., 2014). Aloe-emodin is a compound with anti-rheumatic, anti-inflammatory and analgesic properties (Nesslany et al., 2009). To our knowledge, this is the first to report the inducing effect of aloe-emodin on chondrogenic differentiation of ATDC5 Cells (Fig. 1).

Fig. 1.

Fig. 1.

Open in a new tab

Chemical structure of Aloe-emodin.

In this study, we found that aloe-emodin had stimulatory effects on ATDC5 cells, leading to increased chondrogenesis. Furthermore, aloe-emodin induced matrix proteoglycan synthesis and the expression of chondrogenic marker genes such as type II collagen and bone sialoprotein (BSP), as well as chondrogenic signaling molecules, including runt-related transcription factor 2 (Runx2) and sex determining region Y-box 9 (Sox9). We suggest here that aloe-emodin can reduce the effect of various diseases associated with skeletal disorders.

MATERIALS AND METHODS

Materials

Aloe-emodin was purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Cell culture medium and fetal bovine serum (FBS) were obtained from Invitrogen (Gaithersburg, MD, USA). PCR primers were purchased from Bioneer (Daejcon, Korea). All other chemicals were purchased from Sigma (St. Louis, MO, USA), and unless otherwise indicated, were purchased as described in the previous paper by Choi et al. (2011). The resulting Intracellular purple formazan was quantified using a spectrophotometer to measure the absorbance at a wavelength of 540 nm.

Cell culture and differentiation

Pre-chondrogenic ATDC5 cells were purchased from the RIKEN Cell Bank (Ibaraki, Japan). ATDC5 cells were cultured in a 1:1 mixture of Dulbecco’s modified Eagle’s medium (DMEM) and Hams’ F-12 medium (Invitrogen), including 5% FBS, penicillin (100 U/ml), and streptomycin (100 μg/ml). The cells were cultured in a humidified atmosphere of 5% CO2 at 37°C for different time periods (up to 14 days). The original medium was replaced with a differentiation medium containing 10 μg/ml transferrin, 3×10−8M sodium selenite, 10 μg/ml bovine insulin. In the present study, we used aloe-emodin instead of bovine inulin to induce chondrogenic differentiation of the ATDC5 cells, and the culture medium was replaced every two days.

MTT assay

ATDC5 cells (5×103 cells) were seeded in a 96-well palte with medium and incubated for 24 h with 10% FBS. After the initial incubation period, the cells were treated with varying concentrations of aloe-emodin. Next, the cells were washed with phosphate-buffered saline (PBS) and treated with media containing 100 μg/ml MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] for 2 h at 37°C. The cells were then washed with PBS, and dissolved in 200 μl of DMSO. For the resulting solubilized purple formazan, a quantitative determination of the absorption at 540 nm was carried out using a spectrophotometer.

Alcian blue staining

ATDC5 cells were cultured for 21 days. Cells were washed twice with PBS, and fixed with methanol at −20°C for 5 minutes. They were then stained with 0.1% Alcian blue 8GX in 0.1 M HCL overnight. Cells were washed with 3% acetic acid three times for 30 s and then photographed. Stained cells were dissolved in 10% acetic acid for subsequent quantification of the absorbance at 650 nm (Shukunami et al., 1997).

Reverse transcription-polymerase chain reaction (RT-PCR)

Total RNA was isolated from the ATDC5 cells using a TRIZOL reagent (Invitrogen). cDNA was synthesized from 4 μg of total RNA using SuperScript II reverse transcriptase (Invitrogen) according to the manufacturer’s instructions. PCR primers were purchased from Bioneer (Daejeon, Korea). The gene-specific primers used for the PCR reactions, primer sequences and conditions are listed in Table 1. The reaction was initiated at 95°C for 1 minute. Amplification was performed for various cycles. Every cycle consisted of denaturation for 30 s at 94°C, annealing for 1 minute at the primer-pair specific temperature, and extension for 2 minutes at 72°C using Taq polymerase (Promega, Madison, WI, USA). Reaction products (10 μl) were separated on a 0.8% agarose gel stained with ethidium bromide, and analyzed densitometrically. Band intensity was analyzed by densitometry using a phosphoimager and Quantity One version 4.3.1 software (Bio-Rad, Hercules, CA, USA).

Table 1.

Primer sequences and conditions for RT-PCR

Target genes (Accession number) Primers Forward/Reverse PCR condition
Tm (ºC) Cycles Size (bp)
Collagen II (NM_031163) 5′-ctgtaagaacagcatcgcctacctg-3′ 60 27 271
5′-caggaatttggtgtggacataggg-3′
Aggrecan (NM_007424) 5′-catgagagaggccaatggaacg-3′ 55 27 257
5′-gaatcacctgcacagacccaa-3′
Collagen I (NM_007742) 5′-ttctcctggtaaagatggtgc-3′ 50 35 254
5′-tgttaaaggtgatgctggtcc-3′
Collagen X (NM_009925) 5′-cgtctctgcttttactgtca-3′ 48 35 300
5′-ctcacagaaaatgaccaggt-3′
Runx2 (NM_009820) 5′-actttctccaggaagactgc-3′ 50 37 366
5′-acagcaacagcaacaacagc-3′
Osterix (AF184902) 5′-actacccacccttccctcac-3′ 55 33 360
5′-ccttaacccagctccctacc-3′
BSP (NM_008318) 5′-gagccaggactgccgaaaggaa-3′ 60 29 653
5′-gcagcagcggaggagaaacgg-3′
GAPDH (NM_008084) 5′-accacagtccatgccatcac-3′ 56 25 452
5′-tacagcaacagggtggtgga-5″
Open in a new tab

Alkaline phosphatase (ALP) activity

Cells were harvested and homogenized in a lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA). The lysed suspension was then centrifuged at 13,200×g for 15 min and the supernatant was collected. The cellular protein concentration was evaluated by a Bradford assay. ALP activity was measured by a spectrophotometer with para-nitrophenylphosphate (Sigma) as the substrate. Optical density was measured at 405 nm using an enzyme-linked immunosorbent assay (ELISA) reader.

Western blot analysis

Following treatment, ATDC5 cells were washed with ice-cold phosphate-buffered saline (PBS) and lysed in an ice-cold lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP40, 0.25% sodium deoxycholate, 1 mM EDTA, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 μg/ml leupeptin, 1 μg/ml pepstatin, 5 μg/ml aprotinin, and 20 mM NaF), and kept on ice for 40 minutes. Cell lysates were centrifuged at 13,200 g at 4°C for 10 minutes and the supernatants were stored at −80°C for analysis. The proteins were electrophoresed by 10% SDS-PAGE and then transferred to a polyvinylidene difluoride (PVDF) membrane. Next, a 5% nonfat milk in Tris-buffered saline (TBS) containing 0.25% Tween-20 (TTBS) was used to block the membranes at 16°C for 1 h. The rabbit anti-phospho ERK (Cell Signaling Technology Inc., Beverly, MA, USA), anti-phospho p38 (Cell Signaling Technology), anti-phospho JNK (Cell signaling Technology), anti-ERK (Cell Signaling Technology), anti-JNK (Cell signaling Technology), anti-p38 (Cell Signaling Technology), anti-BMP-2 (Abcam, Cambridge, MA, USA), and anti-ALP (Santa Cruz Biotechnology) antibodies were diluted to 1:500–1:1,000 in 5% nonfat milk in TTBS. Secondary antibodies were diluted with 1:5000–1:10,000 in 5% nonfat skim in TTBS for 1 h at room temperature. Blots were developed with an ECL western blot detection reagent (Amersham Biosciences, Piscataway, NJ, USA) and exposed to X-ray film.

Statistical analysis

The experiments were repeated at least three times, and all data were summarized as the mean ± SEM. All statistical analyses were performed using the SPSS ver. 13.0 software. Statistical significance was set at p less than 0.05.

RESULTS

Effect of aloe-emodin on proliferation and differentiation of ATDC5 cells

Light microscopy was used to measure the in vitro effect of aloe-emodin on matrix proteoglycan formation as well as ATDC5 cell proliferation and differentiation. Cells were treated with aloe-emodin at different concentrations (1 μM, 2.5 μM, 5 μM, 10 μM and 15 μM) for 72 h and assessed with the MTT assay. Aloe-emodin at 1 μM, 2.5 μM, 5 μM, 10 μM concentrations exhibited no cytotoxic effects on ATDC5 compared to the control cells. However, aloe-emodin at 15μMconcentration showed high toxicity (Fig. 2A).

Fig. 2.

Fig. 2.

Open in a new tab

Effects of aloe-emodin on proliferation and differentiation of ATDC5 cells. ATDC5 cells were treated with indicated concentrations of aloe-emodin for 3 days and cell viability was measured by an MTT assay (A). Cells were incubated with aloe-emodin (2.5 μM, 5 μM, 10 μM) and 10 μg/ml insulin, and plated with (5×104) cells per well with 24-multiwell plates for 14 days. Stained cells were dissolved in 10% acetic acid for quantification of the absorbance at 650 nm (B). The normalized data was shown in (C) where the asterisk (*) indicates a significant difference (p<0.05) compared to the control. Each histogram represents the mean ± SE (n=3).

We used alcian blue staining to verify the production of matrix proteoglycan after treatment for 14 days with aloe-emodin in ATDC5 cells (Fig. 2B, 2C). Compared with the control cells, the size and number of stained nodules were significantly increased by aloe-emodin in a concentration-dependent manner in ATDC5 cells. These results suggest that aloe-emodin can induce the differentiation of ATDC5 cells.

Effects of aloe-emodin on alkaline phosphatase activity, BMP-2 and ALP in ATDC5 cells

The enzymatic activity of alkaline phosphatase (ALP) was determined in cells treated with 10 μM aloe-emodin and compared to cells treated with insulin. ALP activity was significantly increased in cells treated with 10 μM aloe-emodin compared to the control cells. ALP activity was also increased in cells treated with 10 μg/ml insulin compared to control cells after 14 days (Fig. 3A). To determine the role of aloe-emodin activation of chondrogenesis in ATDC5 cells via BMP-2 and ALP signaling pathways, we treated ATDC5 cells with aloe-emodin in a time-dependent manner. Treatment with 5 μM aloe-emodin significantly increased the expression of BMP-2 at day 1, and insulin increased the expression of BMP-2 at day 2. Furthermore, the expression of ALP was also significantly increased by 5 μM aloe-emodin after 24 h and insulin increased the expression of ALP after 48 h (Fig. 3B).

Fig. 3.

Fig. 3.

Open in a new tab

Effect of aloe-emodin on alkaline phosphatase activity, BMP-2 and ALP in ATDC5 cells. ATDC5 cells were treated with 10 μM aloe-emodin and 10 μg/ml insulin for 21 days, the level of alkaline phosphatase activity (%) compared with control and insulin-treated cells (A). The ATDC5 cells were treated with 5 μM aloe-emodin and 10 μg/ml insulin for 1, 2, 3 days and cells lysates were immunoblotted with antibody against ALP and BMP-2 (B). Each gaph represents the mean ± S.E.M. (n=3).

Expression of chondrogenic marker genes in ATDC5 cells treated with aloe-emodin

Aloe-emodin significantly increased the expression of chondrogenic marker genes such as Aggrecan, bone sialoprotein (BSP) and Runx2 (Fig. 4A). To determine the stimulatory effect of aloe-emodin on chondrogenesis, the expressions of type II collagen, Aggrecan, type I collagen, type X collagen, Runx2, BSP, and Osterix were measured using real-time PCR (Fig. 4B). ATDC5 cells were treated with 5 μM aloe-emodin at different time intervals. The expressions of type II collagen, Aggrecan, type I collagen, and Osterix were significantly increased at 14 days. Similarly, type X collagen and Runx2 were also increased at 14 days and still in the stable state observation at 21 days. The expression pattern was similar to that of insulin, which was used as a positive control. In addition, BSP had significant expression at 21 days.These results suggest that aloe-emodin induces chondrogenic differentiation in ATDC5 cells.

Fig. 4.

Fig. 4.

Open in a new tab

Expression of chondrogenic marker genes in ATDC5 cells treated with aloe-emodin. ATDC5 cells were treated with 2.5 μM, 5 μM, 10 μM aloe-emodin for 21 days. The mRNA levels of different chondrogenic marker molecules, including Aggrecan, BSP and Runx2 were determined by RT-PCR analysis and compared to the levels of GAPDH (A). ATDC5 cells were treated with 5 μM aloe-emodin or 10 μg/ml insulin were incubated for the indicated time periods (B). Relative expression of type II collagen, Aggrecan, type I collagen, type X collagen, Runx2, BSP and Osterix were observed by RT-PCR analysis and compared to GAPDH.

Effect of aloe-emodin on MAP kinase activation in ATDC5 cells

Next, we investigated whether aloe-emodin had any effects on mitogen-activated protein kinase (MAPKs) or not. MAPK is involved in signal transduction networks and contributes to a diverse range of cellular events, including cell differentiation (Bobick et al., 2007), proliferation (Longobardi et al., 2006), migration (Kuang et al., 2008) and apoptosis (Junttila et al., 2008). Insulin was used as a positive control, and aloe-emodin was used for comparison of the phosphorylation of ERK, JNK and p38. When cells were treated with 10 μM aloe-emodin, the p-ERK significantly increased at 0.5 h, similar to the insulin group. (Fig. 5). This result suggests that aloe-emodin can modulate the differentiation of ATDC5 cells via the ERK signaling pathway.

Fig. 5.

Fig. 5.

Open in a new tab

Effect of aloe-emodin on MAP kinase activation in ATDC5 cells. Cells were cultured in a serum free media for 16 h, and then treated with 10 μM aloe-emodin or 10 μg/ml insulin for indicated times. The cells extracts were using specific antibodies against the phosphorylated forms of the MAPKs and analyzed by Western blot. These data were compared to data obtained with antibodies directed against the unphosphorylated states of the kinase.

Effect of MAP kinase inhibitor on chondrogenesis with aloe-emodin in ATDC5 cells

To demonstrate the effect of aloe-emodin on the induction of ERK during ATDC5 cell differentiation, cells were pretreated cells with 20 μM PD 98059 for 30 minutes, followed by treatment with aloe-emodin for 14 days. Alcian blue staining demonstrated that cells treated with aloe-emodin showed significant increases in the size and number of nodules while treatment with PD 98059 significantly inhibited the increase (Fig. 6). The data suggested that aloe-emodin can induce ATDC5 cells differentiation via the ERK signaling pathway.

Fig. 6.

Fig. 6.

Open in a new tab

Effect of MAP kinase inhibitor on chondrogenesis with aloe-emodin in ATDC5 cells. ATDC5 cells were treated with aloe-emodin and seeded at a density of (5×104) cells per well for 14 days in the presence or absence of 20 μM PD 98059 (A). Stained cells were dissolved in 10% acetic acid for subsequent quantification of the absorbance at 650 nm (B). Each histogram represents the mean ± S.E.M. (n=3).

DISCUSSION

Chondrogenesis is an important biological process involved in tissue patterning bone development, and endochondral ossification. Chondrogensis begins with the formation of multipotent mesenchymal cells which proliferate and differentiate into chondrocytes (Kronenberg, 2003). Chondrocyte cellular bio-synthetic activities of optimal maintenance histories led to the development of cartilage matrix concentration and structural organization (Mauck et al., 2006). However, there are many factors that can influence longitudinal bone growth (Pass et al., 2009). Nutritional, hormonal, and mechanical factors all have effects on cell proliferation, hypertrophy, death, and bone formation.

Chondrogenic differentiation molecular mechanisms during in vitro endochondral bone formation has been used by chondrocytes or established chondrogenic cell lines. The mouse embryonal carcinoma-derived cell line ATDC5 cells are a good model of both in vitro endochondral bone growth control and of differentiation of chondroprogenitor cells. Previous studies have described the method in detail the ATDC5 differentiation and mineralization (Shukunami et al., 1997). This method has provided a reliable source of chondrocyte mineralization for several years and has been widely used in the field since its publication. These cells experience a similar growth plate, which is fully differentiated into hypertrophic chondrocytes in the presence of insulin (Snelling et al., 2010). ATDC5 cells retain the properties of chondroprogenitor cells, and rapidly proliferate in the presence of 5% FBS. Insulin (10 micrograms/ml) induced chondrogenic differentiation of the cells in a post-confluent phase through a cellular condensation process, resulting in the formation of cartilage nodules (Shukunami et al., 1997). In our study, ATDC5 cells produced more cartilaginous nodules than the control cells. Alcian blue staining of the ATDC5 cells was more intense, suggesting greater synthesis of matrix proteoglycans. Aloe-emodin treated cells exhibited increased ALP activity. Moreover, the expressions of chondrogenic marker genes, such as type I collagen, type II collagen, type X collagen, bone sialoproten and Runx2, were induced by aloe-emodin treatment.

Interaction of the MAPK pathway and extracellular signals (e.g., stress induced cytokines, growth factors, and hormones) results in a variety of physiological responses including cell proliferation, differentiation and apoptosis (Roberts and Der, 2007). MAPK and BMP signaling pathways both contribute to chondrogenic signaling. The MAPK pathway, including ERK and p38, plays a key role in many types of cell differentiation signaling processes (Oh et al., 2000). In addition, JNK is known to control cell proliferation, differentiation, and apoptosis (Davis, 2000). In the present study, we showed that treating ATDC5 cells with aloe-emodin results in the activation of ERK. BMP-2 belongs to the transforming growth factor beta (TGF-β) super-family. BMPsare initially determined byinducing the ectopic bone and cartilage formation of its unique ability (Otsuki et al., 2010). However, it also play an important role in the earliest stages of chondrogenesis. BMP-2 induces chondrogenic differentiation and chondrocyte proliferation (Yoon and Lyons, 2004), and markedly up-regulates the expression of type X collagen mRNA in late-phase differentiation (Akiyama et al., 2000). BMP-2 also stimulates RunX expression and ALP, a widely accepted bone marker (Kim et al., 2004). BMP-2 can be detected in the health articular cartilage, but it is highly expressed in osteoarthritis articular cartilage and subjected to mechanical damage of articular chondrocytes and synovial cells, possibly cause anabolic cartilage cells formation and development of osteophyte (van Beuningen et al., 1988; Nakase et al., 2003). In our study, aloe-emodin significantly increased the expression of BMP-2 in ATDC5 cells, suggesting that aloe-emodin may activate chondrogenesis through the BMP-2 signaling pathway in addition to the ERK and ALP signaling pathways.

Acknowledgments

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A2A16055076).

REFERENCES

  1. Akiyama H, Shukunami C, Nakamura T, Hiraki Y. Differential expressions of BMP family genes during chondrogenic differentiation of mouse ATDC5 cells. Cell Struct Funct. 2000;25:195–204. doi: 10.1247/csf.25.195. [DOI] [PubMed] [Google Scholar]
  2. Bobick BE, Thornhill TM, Kulyk WM. Fibroblast growth factors 2, 4, and 8 exert both negative and positive effects on limb, frontonasal, and mandibular chondrogenesis via MEK-ERK activation. J Cell Physiol. 2007;211:233–243. doi: 10.1002/jcp.20923. [DOI] [PubMed] [Google Scholar]
  3. Choi HJ, Nepal M, Park YR, Lee HK, Oh SR, Soh Y. Stimulation of chondrogenesis in ATDC5 chondroprogenitor cells and hypertrophy in mouse by Genkwadaphnin. Eur J Pharmacol. 2011;655:9–15. doi: 10.1016/j.ejphar.2011.01.012. [DOI] [PubMed] [Google Scholar]
  4. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000;103:239–252. doi: 10.1016/S0092-8674(00)00116-1. [DOI] [PubMed] [Google Scholar]
  5. Huang Q, Shen HM, Ong CN. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway. Cell Mol Life Sci. 2005;62:1167–1175. doi: 10.1007/s00018-005-5050-2. [DOI] [PubMed] [Google Scholar]
  6. Hu BY, Zhang H, Meng XL, Wang F, Wang P. Aloe-emodin from rhubarb (Rheum rhabarbarum) inhibits lipopolysac-charide-induced inflammatory responses in RAW264.7 macrophages. J Ethnopharmacol. 2014;153:846–853. doi: 10.1016/j.jep.2014.03.059. [DOI] [PubMed] [Google Scholar]
  7. Jiang C, Ma P, Ma B, Wu Z, Qiu G, Su X, Xia Z, Ye Z, Wang Y. Plasma-derived fibronectin stimulates chondrogenic differentiation of human subchondral cortico-spongious progenitor cells in late-stage osteoarthritis. Int J Mol Sci. 2015;16:19477–19489. doi: 10.3390/ijms160819477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Junttila MR, Li SP, Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 2008;22:954–965. doi: 10.1096/fj.06-7859rev. [DOI] [PubMed] [Google Scholar]
  9. Komatsu K, Nagayama Y, Tanaka K, Ling Y, Basnet P, Meselhy MR. Development of a high performance liquid chromatographic method for systematic quantitative analysis of chemical constituents in rhubarb. Chem Pharm Bull. 2006;54:941–947. doi: 10.1248/cpb.54.941. [DOI] [PubMed] [Google Scholar]
  10. Kim JY, Cheon YH, Kwak SC, Baek JM, Yoon KH, Lee MS, Oh J. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation. J Bone Miner Res. 2014;29:1541–1553. doi: 10.1002/jbmr.2183. [DOI] [PubMed] [Google Scholar]
  11. Kim MS, Park MJ, Kim SJ, Lee CH, Yoo H, Shin SH, Song ES, Lee SH. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells. Int J Oncol. 2005;27:839–846. [PubMed] [Google Scholar]
  12. Kim YJ, Lee MH, Wozney JM, Cho JY, Ryoo HM. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem. 2004;279:50773–50780. doi: 10.1074/jbc.M404145200. [DOI] [PubMed] [Google Scholar]
  13. Kronenberg HM. Developmental regulation of the growth plate. Nature. 2003;423:332–336. doi: 10.1038/nature01657. [DOI] [PubMed] [Google Scholar]
  14. Kuang D, Zhao X, Xiao G, Ni J, Feng Y, Wu R, Wang G. Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK. Basic Res Cardiol. 2008;103:265–273. doi: 10.1007/s00395-007-0690-z. [DOI] [PubMed] [Google Scholar]
  15. Lin JG, Chen GW, Li TM, Chouh ST, Tan TW, Chung JG. Aloe-emodin induces apoptosis in T24 human bladder cancer cells through the p53 dependent apoptotic pathway. J Urol. 2006;175:343–347. doi: 10.1016/S0022-5347(05)00005-4. [DOI] [PubMed] [Google Scholar]
  16. Longobardi L, O’Rear L, Aakula S, Johnstone B, Shimer K, Chytil A, Horton WA, Moses HL, Spagnoli A. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res. 2006;21:626–636. doi: 10.1359/jbmr.051213. [DOI] [PubMed] [Google Scholar]
  17. Mauck RL, Yuan X, Tuan RS. Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthr Cartil. 2006;14:179–189. doi: 10.1016/j.joca.2005.09.002. [DOI] [PubMed] [Google Scholar]
  18. Mijatovic S, Maksimovic-Ivanic D, Radovic J, Miljkovic D, Kaludjerovic GN, Sabo TJ, Trajkovic V. Aloe-emodin decreases the ERK-dependent anticancer activity of cisplatin. Cell Mol Life Sci. 2005;62:1275–1282. doi: 10.1007/s00018-005-5041-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mueller SO, Stopper H, Dekant W. Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes. Bioactivation to genotoxic metabolites. Drug Metab Dispos. 1998;26:540–546. [PubMed] [Google Scholar]
  20. Nakase T, Miyaji T, Tomita T, Kaneko M, Kuriyama K, Myoui A, Sugamoto K, Ochi T, Yoshikawa H. Localization of bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte. Osteoarthr Cartil. 2003;11:278–284. doi: 10.1016/S1063-4584(03)00004-9. [DOI] [PubMed] [Google Scholar]
  21. Nesslany F, Simar-Meintières S, Ficheux H, Marzin D. Aloe-emodin-induced DNA fragmentation in the mouse in vivo comet assay. Mutat Res. 2009;678:13–19. doi: 10.1016/j.mrgentox.2009.06.004. [DOI] [PubMed] [Google Scholar]
  22. Oh CD, Chang SH, Yoon YM, Lee SJ, Lee YS, Kang SS, Chun JS. Opposing role of mitogen-activated protein kinase subtypes, Erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes. J Biol Chem. 2000;275:5613–5619. doi: 10.1074/jbc.275.8.5613. [DOI] [PubMed] [Google Scholar]
  23. Otsuki S, Hanson SR, Miyaki S, Grogan SP, Kinoshita M, Asahara H, Wong CH, Lotz MK. Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways. Proc Natl Acad Sci USA. 2010;107:10202–10207. doi: 10.1073/pnas.0913897107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pass C, MacRae VE, Ahmed SF, Farquharson C. Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth. Cell Biochem Funct. 2009;27:119–127. doi: 10.1002/cbf.1551. [DOI] [PubMed] [Google Scholar]
  25. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147. doi: 10.1126/science.284.5411.143. [DOI] [PubMed] [Google Scholar]
  26. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26:3291–3310. doi: 10.1038/sj.onc.1210422. [DOI] [PubMed] [Google Scholar]
  27. Shukunami C, Ishizeki K, Atsumi T, Ohta Y, Suzuki F, Hiraki Y. Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J Bone Miner Res. 1997;12:1174–1188. doi: 10.1359/jbmr.1997.12.8.1174. [DOI] [PubMed] [Google Scholar]
  28. Snelling SJ, Hulley PA, Loughlin J. BMP5 activates multiple signaling pathways and promotes chondrogenic differentiation in the ATDC5 growth plate model. Growth Factors. 2010;28:268–279. doi: 10.3109/08977191003752296. [DOI] [PubMed] [Google Scholar]
  29. van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB. Differential effects of local application of BMP-2 or TGF- β1 on both articular cartilage composition and osteophyte formation. Osteoarthr Cartil. 1988;6:306–317. doi: 10.1053/joca.1998.0129. [DOI] [PubMed] [Google Scholar]
  30. Wakitani S, Goto T, Young RG, Mansour JM, Goldberg VM, Caplan AI. Repair of large full-thickness articular cartilage defects with allograft articular chondrocytes embedded in a collagen gel. Tissue Eng. 1998;4:429–444. doi: 10.1089/ten.1998.4.429. [DOI] [PubMed] [Google Scholar]
  31. Yoon BS, Lyons KM. Multiple functions of BMPs in chondrogenesis. J Cell Biochem. 2004;93:93–103. doi: 10.1002/jcb.20211. [DOI] [PubMed] [Google Scholar]
  32. Zuscik MJ, Hilton MJ, Zhang XP, Chen D, O’Keefe RJ. Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest. 2008;118:429–438. doi: 10.1172/JCI34174. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biomolecules & Therapeutics are provided here courtesy of Korean Society of Applied Pharmacology

RESOURCES